733 related articles for article (PubMed ID: 33964682)
1. Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan.
Kishi T; Ikuta T; Sakuma K; Okuya M; Iwata N
J Psychiatr Res; 2021 Jun; 138():444-452. PubMed ID: 33964682
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Kishi T; Iwata N
CNS Drugs; 2013 Sep; 27(9):731-41. PubMed ID: 23812802
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
[TBL] [Abstract][Full Text] [Related]
4. Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):191-202. PubMed ID: 28219485
[TBL] [Abstract][Full Text] [Related]
5. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
[TBL] [Abstract][Full Text] [Related]
6. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population.
Kishi T; Ikuta T; Matsunaga S; Matsuda Y; Oya K; Iwata N
Neuropsychiatr Dis Treat; 2017; 13():1281-1302. PubMed ID: 28553116
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.
Harvey RC; James AC; Shields GE
CNS Drugs; 2016 Jan; 30(1):27-39. PubMed ID: 26801655
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta-analysis of phase 3 trials in Japan.
Kishi T; Nosaka T; Sakuma K; Okuya M; Iwata N
Neuropsychopharmacol Rep; 2020 Sep; 40(3):314-322. PubMed ID: 32767739
[TBL] [Abstract][Full Text] [Related]
10. Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis.
Rogdaki M; McCutcheon RA; D'Ambrosio E; Mancini V; Watson CJ; Fanshawe JB; Carr R; Telesia L; Martini MG; Philip A; Gilbert BJ; Salazar-de-Pablo G; Kyriakopoulos M; Siskind D; Correll CU; Cipriani A; Efthimiou O; Howes OD; Pillinger T
Lancet Child Adolesc Health; 2024 Jul; 8(7):510-521. PubMed ID: 38897716
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
Leucht S; Cipriani A; Spineli L; Mavridis D; Orey D; Richter F; Samara M; Barbui C; Engel RR; Geddes JR; Kissling W; Stapf MP; Lässig B; Salanti G; Davis JM
Lancet; 2013 Sep; 382(9896):951-62. PubMed ID: 23810019
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
13. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
14. Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials.
Kishi T; Matsuda Y; Nakamura H; Iwata N
J Psychiatr Res; 2013 Feb; 47(2):149-54. PubMed ID: 23131856
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Kishi T; Matsui Y; Matsuda Y; Katsuki A; Hori H; Yanagimoto H; Sanada K; Morita K; Yoshimura R; Shoji Y; Hagi K; Iwata N
Pharmacopsychiatry; 2019 Feb; 52(2):52-62. PubMed ID: 29514360
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Kishi T; Matsuda Y; Iwata N
PLoS One; 2014; 9(2):e88049. PubMed ID: 24505373
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
18. Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study.
Harvey PD; Nakamura H; Miura S
Neuropsychopharmacol Rep; 2020 Mar; 40(1):63-72. PubMed ID: 31788985
[TBL] [Abstract][Full Text] [Related]
19. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
